|
|
||||||||
a Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts, USA
b Department of Ophthalmology, Nippon Medical School, Tokyo, Japan
c Stem Cell Research, Childrens Hospital of Orange County, Orange, California, USA
Key Words. Stem cells • Transplantation • MHC • Tolerance • Suppression • Anergy • Neural
Michael J. Young, Ph.D., Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, Massachusetts, USA 02114. Telephone: 617-912-7419; Fax: 617-912-0101; e-mail: mikey{at}vision.eri.harvard.edu
Multipotent, self-renewing stem and progenitor cells isolated from the mammalian central nervous system (CNS) have been shown to survive as allografts following transplantation to sites throughout the neuraxis. However, studies of this type shed little light upon the immunologic properties of the cells themselves, primarily because little is learned about the intrinsic immunogenic properties of a cell when it is grafted into an immune-privileged site. We have therefore investigated the immunogenic and antigenic properties of CNS progenitor cells by grafting them into a conventional (i.e., non-immune-privileged) site, namely, beneath the kidney capsule. Our results indicate that allogeneic CNS progenitor cells survive at least 4 weeks in a conventional site, during which time they neither sensitize their hosts nor express detectable levels of major histocompatibility complex (MHC) class I or II. These in vivo data are in accord with flow cytometric results showing that CNS progenitor cells do not express MHC class I or class II, either at baseline or upon differentiation in 10% serum. Exposure to interferon gamma, however, reversibly upregulates expression of these key transplantation antigens. Together, these results reveal CNS progenitor cells to possess inherent immune privilege. Since CNS progenitor cell allografts were rejected beneath the kidney capsule following specific sensitization of the host, CNS progenitor cells were able to display alloantigens, albeit not in an immunogenic form.
This article has been cited by other articles:
![]() |
M Muraca, C Ferraresso, M T Vilei, A Granato, M Quarta, E Cozzi, M Rugge, K A Pauwelyn, M Caruso, I Avital, et al. Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat Gut, December 1, 2007; 56(12): 1725 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Ng, E. Lavik, H. Keino, A. W. Taylor, R. S. Langer, and M. J. Young Creating an Immune-Privileged Site Using Retinal Progenitor Cells and Biodegradable Polymers Stem Cells, June 1, 2007; 25(6): 1552 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pisati, M. Belicchi, F. Acerbi, C. Marchesi, C. Giussani, M. Gavina, S. Javerzat, M. Hagedorn, G. Carrabba, V. Lucini, et al. Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models Cancer Res., April 1, 2007; 67(7): 3054 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-E. Kim, K. Tsuji, Y. R. Kim, F.-J. Mueller, H.-S. Eom, E. Y. Snyder, E. H. Lo, R. Weissleder, and D. Schellingerhout Neural Stem Cell Transplant Survival in Brains of Mice: Assessing the Effect of Immunity and Ischemia by using Real-time Bioluminescent Imaging Radiology, December 1, 2006; 241(3): 822 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tomita, T. Mori, K. Maruyama, T. Zahir, M. Ward, A. Umezawa, and M. J. Young A Comparison of Neural Differentiation and Retinal Transplantation with Bone Marrow-Derived Cells and Retinal Progenitor Cells Stem Cells, October 1, 2006; 24(10): 2270 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Madhavan, V. Ourednik, and J. Ourednik Increased "Vigilance" of Antioxidant Mechanisms in Neural Stem Cells Potentiates Their Capability to Resist Oxidative Stress Stem Cells, September 1, 2006; 24(9): 2110 - 2119. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, A. Yoshida, H. Kawashima, M. Ishizaki, H. Takahashi, and J. Hori Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1522 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Warfvinge, J. F. Kiilgaard, E. B. Lavik, E. Scherfig, R. Langer, H. J. Klassen, and M. J. Young Retinal Progenitor Cell Xenografts to the Pig Retina: Morphologic Integration and Cytochemical Differentiation Arch Ophthalmol, October 1, 2005; 123(10): 1385 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, A. Tessler, S. S. W. Han, I. Fischer, M. S. Rao, and M. E. Selzer Fate of Immortalized Human Neuronal Progenitor Cells Transplanted in Rat Spinal Cord Arch Neurol, February 1, 2005; 62(2): 223 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhang, B. Joseph, S. Gupta, I. Guest, M. Xu, S. Sell, K.-H. Son, K. S. Koch, and H. L. Leffert Embryonic Mouse STO Cell-Derived Xenografts Express Hepatocytic Functions in the Livers of Nonimmunosuppressed Adult Rats Stem Cells, February 1, 2005; 23(2): 186 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Klassen, T. F. Ng, Y. Kurimoto, I. Kirov, M. Shatos, P. Coffey, and M. J. Young Multipotent Retinal Progenitors Express Developmental Markers, Differentiate into Retinal Neurons, and Preserve Light-Mediated Behavior Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4167 - 4173. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mammolenti, S. Gajavelli, P. Tsoulfas, and R. Levy Absence of Major Histocompatibility Complex Class I on Neural Stem Cells Does Not Permit Natural Killer Cell Killing and Prevents Recognition by Alloreactive Cytotoxic T Lymphocytes In Vitro Stem Cells, November 1, 2004; 22(6): 1101 - 1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Abraham, S. Kodama, J. C. Lin, M. Ubeda, D. L. Faustman, and J. F. Habener Human Pancreatic Islet-Derived Progenitor Cell Engraftment in Immunocompetent Mice Am. J. Pathol., March 1, 2004; 164(3): 817 - 830. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
